The department of science and innovation says the state-backed vaccine developer Biovac has met its expectations, despite the fact that it has yet to manufacture any of its own shots more than 15 years after its inception.

Biovac is a public-private partnership that was established in 2003 to revive SA’s human vaccine manufacturing capacity. Earlier this week, it emerged that the health department is running a new tender that threatens Biovac’s income, raising questions about how the government sees the future of this venture.

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now